Guizhou Yibai Pharmaceutical Co., Ltd. (SHSE: 600594)
Health Care · Pharmaceuticals · CN
CN¥3.64
+0.83% today · -10.8% 1Y
Guizhou Yibai Pharmaceutical Co., Ltd. (SHSE: 600594) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $425.65M and employs 4,832 people.
Over the last twelve months the share price has lost 10.8%, trading between 2.85 and 5.27.
Tweenvest scores Guizhou Yibai Pharmaceutical Co., Ltd. across four factors: quality 71/100, value 45/100, growth 11/100. Its strongest factor is quality.
600594 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $425.65M
- Revenue (TTM)
- $229.53M
- P/E
- —
- EPS
- -0.50
- Dividend yield
- —
- Beta (5Y)
- 0.20
- 52-week high
- CN¥5.27
- 52-week low
- CN¥2.85
- Avg volume (3M)
- —
- Shares outstanding
- 784.39M
- Employees
- 4,832
- Next earnings
- —
About Guizhou Yibai Pharmaceutical Co., Ltd.
Guizhou Yibai Pharmaceutical Co., Ltd. is a Chinese pharmaceutical enterprise that encompasses the full spectrum of activities from researching and developing new drugs to their production and commercialization throughout the country. The company offers a diverse portfolio of medications, available in various dosage forms including capsules, tablets, granules, syrups, liquid injectables (small-volume), lyophilized powder injections, traditional pills, and oral solutions. These therapeutic agents are designed to address a broad range of medical conditions, specifically targeting oncology, cerebrovascular health, respiratory ailments, rheumatic diseases, digestive disorders, pediatric and gynecological illnesses, alongside providing anti-infective, anti-inflammatory, and pain management solutions. Established in 1995, the company maintains its headquarters in Guiyang, China.
- ISIN
- CNE000001H03
- Founded
- 1995
- Listed since
- Mar 23, 2004
- Exchange
- Shanghai Stock Exchange
- Currency
- CNY
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Gufic Biosciences LimitedBSE: 509079 | $435.58M | Rs418.20 | -1.11% |
| AgomAb Therapeutics NVNasdaqGS: AGMB | $433.38M | $9.22 | +4.77% |
| Shaanxi Panlong Pharmaceutical Group Co., Ltd.SZSE: 002864 | $432.06M | CN¥21.05 | +0.48% |
| Nika Pharmaceuticals, Inc.OTCPK: NIKA | $431.19M | $— | — |
| Anhui Fengyuan Pharmaceutical Co., Ltd.SZSE: 000153 | $423.27M | CN¥6.11 | +0.33% |
| Renata PLCDSE: RENATA | $418.17M | Tk448.70 | -0.09% |
| Chengdu huasun technology group Inc. , LTD.SZSE: 000790 | $410.99M | CN¥4.42 | -5.56% |
| Zhejiang East Asia Pharmaceutical Co., Ltd.SHSE: 605177 | $407.06M | CN¥24.26 | -6.19% |
Figures last refreshed Oct 4, 2026.